LIM
Lingotto Investment Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.6M | Hold |
3,675,077
| – | – | 0.4% | 22 |
|
|
2025
Q1 | $19.4M | Hold |
3,675,077
| – | – | 0.51% | 22 |
|
|
2024
Q4 | $24.8M | Hold |
3,675,077
| – | – | 0.67% | 21 |
|
|
2024
Q3 | $24.2M | Hold |
3,675,077
| – | – | 0.7% | 21 |
|
|
2024
Q2 | $27.6M | Buy |
3,675,077
+1,500,000
| +69% | +$11.3M | 0.93% | 19 |
|
|
2024
Q1 | $21.7M | Buy |
2,175,077
+300,000
| +16% | +$2.99M | 0.91% | 19 |
|
|
2023
Q4 | $18.5M | Buy |
1,875,077
+1,100,000
| +142% | +$10.8M | 0.89% | 19 |
|
|
2023
Q3 | $5.93M | Hold |
775,077
| – | – | 0.32% | 26 |
|
|
2023
Q2 | $5.79M | Buy |
+775,077
| New | +$5.79M | 0.37% | 26 |
|